Syncom Formulations (India) Limited (BOM:524470)

India flag India · Delayed Price · Currency is INR
11.86
-0.14 (-1.17%)
At close: Mar 9, 2026
-24.79%
Market Cap 11.15B
Revenue (ttm) 5.03B
Net Income (ttm) 689.58M
Shares Out 940.00M
EPS (ttm) 0.70
PE Ratio 17.02
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 196,856
Average Volume 182,033
Open 11.91
Previous Close 12.00
Day's Range 11.53 - 11.99
52-Week Range 11.36 - 23.46
Beta 0.52
RSI 32.47
Earnings Date Feb 12, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1988
Employees 744
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524470
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.

Financial Statements

News

There is no news available yet.